COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2861: Articles 28601-28610  | Next

ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS
TEMIME, L., Gustin, M.-P., Duval, A., Buetti, N., Crepey, P., Guillemot, D., Thiebaut, R., Vanhems, P., Zahar, J.-R., Smith, D. R., Opatowski, L., Modelling COVID-19 in hospitals REACTinG AVIESAN working group
10.1101/2020.04.20.20072462 — Posted: 2020-04-24
Estimation of Undetected Covid-19 Infections in India
Mukhopadhyay, S., Chakraborty, D.
10.1101/2020.04.20.20072892 — Posted: 2020-04-24
Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods
Boehning, D., Rocchetti, I., Maruotti, A., Holling, H.
10.1101/2020.04.20.20072629 — Posted: 2020-04-24 Discussion: Onsite
Using EpiRank for Analyzing Emerging Coronavirus Epidemic Patterns
Chin, W. C. B., Huang, C.-Y.
10.1101/2020.04.20.20072736 — Posted: 2020-04-24 Discussion: Onsite
Prediction of the Peak, Effect of Intervention and Total Infected by the CoronavirusDisease in India
Shah, P. V.
10.1101/2020.04.20.20072793 — Posted: 2020-04-24 Discussion: Onsite
Estimating the burden of SARS-CoV-2 in France
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hoze, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., Cauchemez, S.
10.1101/2020.04.20.20072413 — Posted: 2020-04-24
Predicting mortality attributable to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
Bello-Chavolla, O. Y., Bahena-Lopez, J. P., Antonio-Villa, N. E., Vargas-Vazquez, A., Gonzalez-Diaz, A., Marquez-Salinas, A., Fermin-Martinez, C. A., Naveja, J. J., Aguilar-Salinas, C. A.
10.1101/2020.04.20.20072223 — Posted: 2020-04-24 Discussion: Onsite
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection
Lala, A., Johnson, K. W., Russak, A. J., Paranjpe, I., Zhao, S., Manna, S., Solani, S., Vaid, A., Chaudhry, F., De Freitas, J. K., Fayad, Z. A., Pinney, S. P., Levin, M., Charney, A., Bagiella, E., Narula, J., Glicksberg, B. S., Nadkarni, G., Januzzi, J., Mancini, D. M., Fuster, V.
10.1101/2020.04.20.20072702 — Posted: 2020-04-24 Discussion: Onsite
A phased approach to unlocking during the COVID-19 pandemic; Lessons from trend analysis
Stedman, M., Davies, M., Anderson, S. G., Lunt, M., Verma, A., Heald, A.
10.1101/2020.04.20.20072264 — Posted: 2020-04-24
The Association of Lymphocyte count and levels of CRP, D-Dimer, and LDH with severe coronavirus disease 2019 (COVID-19): A Meta-Analysis
Ali, A., Mohamed, S., Elkhidir, I., Elbathani, M., Ibrahim, A., Elhassan, A., Salman, M., Elhassan, M., Elnil, M., Abuzied, A.
10.1101/2020.04.20.20072801 — Posted: 2020-04-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).